Skip Navigation
You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Department of Health and Human Services
•
National Institutes of Health
Advanced Search
NIAID Home
Health & Research A to Z
Labs & Scientific Resources
Funding
About NIAID
News & Events
NIAID
>
Labs & Scientific Resources
>
Resources for Researchers
>
DMID Resources for Researchers
>
Phase I Clinical Trial Units for Therapeutics
Resources for Researchers
DMID Resources for Researchers
Phase I Clinical Trial Units for Therapeutics
Eligibility Criteria
Assurances to Users
Application Process
Approval Process
User Requirements
Skip Website Tools
Website Tools
Email this page
Print this page
Get email updates
Order publications
Bookmark & share
Skip Stay Connected
Stay Connected
Contact Info
Elizabeth Hollomon
Project Officer
E-mail:
hollomone@niaid.nih.gov
Javascript Error
Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.
Resources for Researchers
Phase I Clinical Trial Units for Therapeutics
Assurances to UsersĀ
DMID will provide clinical research sites qualified by training and experience, safety oversight, clinical monitoring, data management and regulatory management.
All information provided will be treated as confidential. Users may enter into a Materials Transfer Agreement and/or Clinical Trial Agreement as appropriate.
All PIs and collaborators will retain publication rights.
Last Updated June 30, 2008